HSBC initiates Nuscale Power stock with Hold rating on execution risk

HSBC initiated NuScale Power at Hold with a $13 price target, near the stock's $13.57 trading price, as regulatory progress on its 50 MW and 77 MW modules is offset by execution and funding uncertainty. NuScale’s Europe-first SMR project in Romania is moving to pre-EPC on a $6 billion-$7 billion six-module plan, while the company also benefits from fuel partnership expansion with Framatome and TVA-related deployment prospects. The stock remains highly volatile, down 64% over six months, and the company is still unprofitable despite expected 153% sales growth this year.

Analysis

SMR is transitioning from a pure narrative trade to a bifurcated execution story: regulatory de-risking is real, but the equity still trades like a long-duration option on project conversion rather than a normalized utility supplier. That matters because the market is likely to keep discounting headline design approvals until it sees milestone payments, EPC commitments, and customer-funded dilution absorbed without balance-sheet stress. In other words, the next leg higher is less about engineering validation and more about whether the company can repeatedly monetize validation without having to finance working capital for customers.

The second-order winner is the broader SMR supply chain, not necessarily the developer itself. Fuel fabrication, component manufacturing, and nuclear services names should benefit earlier because they monetize as projects enter pre-EPC and long-lead procurement, while SMR’s own revenue recognition remains back-end loaded and highly milestone dependent. Competitively, this also raises the bar for late entrants: every additional regulatory approval increases the gap between approved designs and aspirational peers, which can force capital allocation away from weaker SMR concepts and toward better-capitalized incumbents.

The contrarian issue is that consensus is likely overestimating how quickly AI-driven power demand converts into SMR order flow. Hyperscalers need firm power, but they also need schedule certainty, and any delay pushes them toward gas, grid interconnect, or utility-scale renewables plus storage in the nearer term. That makes the stock vulnerable to repeated “good news, no cash flow” cycles over the next 6-18 months, especially if risk appetite fades and the market starts funding power narratives more discriminately.

Near term, the key catalyst is whether additional commercial milestones arrive without incremental equity issuance; if not, the stock can retrace sharply despite positive headlines because the valuation is still priced off future project optionality. The bearish setup is a volatility reset after each financing or timeline slip, while the bullish setup requires a sequence of contract wins that convert the current regulatory moat into visible cash receipts. Until that happens, the stock should trade as a high-beta event-driven name rather than a fundamental compounder.

Key Decisions for Investors

• Fade strength in SMR on headline approvals: sell call spreads or trim equity exposure into rallies over the next 2-6 weeks; risk is another contract announcement, but upside looks capped until revenue converts.
• Pair long names exposed to early SMR monetization vs. SMR itself: favor fuel/component/service beneficiaries over the developer over a 3-12 month horizon, since supply-chain revenue should arrive before meaningful project cash flow.
• Use SMR as a volatility trade, not a core long: buy dips only after confirming no near-term equity raise, otherwise the dilution risk can overwhelm contract optimism within 1-2 quarters.
• Monitor for catalyst-driven upside only on milestone conversion; if additional customer-funded commitments are announced, consider a tactical long for a 15-25% pop, but with tight stops on financing risk.
• Avoid chasing the AI power narrative in SMR until there is evidence of repeatable bookings; the better risk/reward is in infrastructure enablers and nuclear services with shorter cash-conversion cycles.